Proteomic identification of malignant transformation-related proteins in esophageal squamous cell carcinoma

Journal of Cellular Biochemistry

Volumn 104, Issue 5, 2008, Pages 1625-1635

  Qi, Yi Jun ^a   He, Qing Yu ^b   Ma, Yuan Fang ^a   Du, Yao Wu ^a   Liu, Guang Chao ^a   Li, Yan Jie ^a   Tsao, George S W ^c   Ngai, Sai Ming ^d   Chiu, Jen Fu ^c  

^a HENAN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Annexin A2; Esophageal squamous cell carcinoma; Malignant transformation associated proteins; Protein profiling; Proteomics

Indexed keywords

CYCLOPHILIN A; DNA BINDING PROTEIN; EUKARYOTIC TRANSLATION INITIATION FACTOR 4A; EXCITATORY AMINO ACID TRANSPORTER 1; FIBRINOGEN; HEAT SHOCK PROTEIN 70; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HISTONE DEACETYLASE; HISTONE DEACETYLASE 10; INITIATION FACTOR; IOXAGLIC ACID; KINESIN; LAMIN A; LAMIN C; LIPOCORTIN 2; PROTEIN DISULFIDE ISOMERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MTSG1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; UPREGULATION; WESTERN BLOTTING;

ANNEXINS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ESOPHAGEAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; PROTEOMICS;

EUKARYOTA;

EID: 50249150192     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21727     Document Type: Article

References (50)

1. Cai YC, Yang GY, Nie Y, Wang LD, Zhao X, Song YL, Seril DN, Liao J, Xing EP, Yang CS. 2000. Molecular alterations of p73 in human esophageal squamous cell carcinomas: Loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53. Carcinogenesis 21:683-689.
2. Campa MJ, Wang MZ, Howard B, Fitzgerald MC, Patz EF, Jr. 2003. Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer. Cancer Res 63:1652-1656.
3. Chen J, He QY, Yuen APW, Chiu JF. 2004. Proteomics of buccal squamous cell carcinoma: The involvement of multiple pathways in tumorigenesis. Proteomics 4:2465-2475.
4. Chetcuti A, Margan SH, Russell P, Mann S, Millar DS, Clark SJ, Roger J, Handelsman DJ, Dong Q. 2001. Loss of annexin II heavy and light chains in prostate cancer and its precursors. Cancer Res 61:6331-6334.
5. Cole SP, Pinkoski MJ, Bhardwaj G, Deeley RG. 1992. Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line. Br J Cancer 65:498-502.
6. Creutz CE. 1992. The annexins and exocytosis. Science 258:924-931.
7. Emoto K, Sawada H, Yamada Y, Fujimoto H, Takahama Y, Ueno M, Takayama T, Uchida H, Kamada K, Naito A, Hirao S, Nakajima Y. 2001a. Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Res 21:1339-1345.
8. Emoto K, Yamada Y, Sawada H, Fujimoto H, Ueno M, Takayama T, Kamada K, Naito A, Hirao S, Nakajima Y. 2001b. Annexin II overexpression correlates with stromal tenascin-C overexpression: A prognostic marker in colorectal carcinoma. Cancer 92:1419-1426.
9. Esteller M. 2002. CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future. Oncogene 21:5427-5440.
10. Faure AV, Migne C, Devilliers G, Ayala-Sanmartin J. 2002, Annexin 2 "secretion" accompanying exocytosis of chromaffin cells: Possible mechanisms of annexin release. Exp Cell Res 276:79-89.
11. Gillette JM, Chan DC, Nielsen-Preiss SM. 2004. Annexin 2 expression is reduced in human osteosarcoma metastases. J Cell Biochem 92:820-832.
12. Guang S, Felthauser AM, Mertz JE. 2005. Binding of hnRNP L to the pre-mRNA processing enhancer of the herpes simplex virus thymidine kinase gene enhances both polyadenylation and nucleocytoplasmic export of intronless mRNAs. Mol Cell Biol 25:6303-6313.
13. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. 1999. Creation of human tumour cells with defined genetic elements. Nature 400: 464-468.
14. Handschumacher RE, Harding MW, Rice J, Drugge RJ, Speicher DW. 1984. Cyclophilin: A specific cytosolic binding protein for cyclosporin A. Science 226:544-547.
15. Harder T, Kellner R, Parton RG, Gruenberg J. 1997. Specific release of membrane-bound annexin II and cortical cytoskeletal elements by sequestration of membrane cholesterol. Mol Biol Cell 8:533-545.
16. He QY, Lau GK, Zhou Y, Yuen ST, Lin MC, Kung HF, Chiu JF. 2003. Serum biomarkers of hepatitis B virus infected liver inflammation: A proteomic study. Proteomics 3: 666-674.
17. Howard BA, Furumai R, Campa MJ, Rabbani ZN, Vujaskovic Z, Wang XF, Patz EF, Jr. 2005. Stable RNA interference-mediated suppression of cyclophilin A diminishes non-small-cell lung tumor growth in vivo. Cancer Res 65:8853-8860.
18. Huang T, Deng H, Wolkoff AW, Stockert RJ. 2002. Phosphorylation-dependent interaction of the asialogly-coprotein receptor with molecular chaperones. J Biol Chem 277:37798-37803.
19. Hui J, Reither G, Bindereif A. 2003. Novel functional role of CA repeats and hnRNP L in RNA stability. RNA 9:931-936.
20. Hui J, Stangl K, Lane WS, Bindereif A. 2003. HnRNP L stimulates splicing of the eNOS gene by binding to variable-length CA repeats. Nat Struct Biol 10:33-37.
21. Ivery MT. 2000. Immunophilins: Switched on protein binding domains? Med Res Rev 20:452-484.
22. Jones PA, Baylin SB. 2002. The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428.
23. Jones PA, Takai D. 2001. The role of DNA methylation in mammalian epigenetics. Science 293:1068-1070.
24. Jones GJ, Heiss NS, Veale RB, Thornley AL. 1993. Amplification and expression of the TGF-alpha, EGF receptor and c-myc genes in four human oesophageal squamous cell carcinoma lines. Biosci Rep 13:303-312.
25. Katayama M, Nakano H, Ishiuchi A, Wu W, Oshima R, Sakurai J, Nishikawa H, Yamaguchi S, Otsubo T. 2006. Protein pattern difference in the colon cancer cell lines examined by two-dimensional differential in-gel electrophoresis and mass spectrometry. Surg Today 36:1085-1093.
26. Klaunig JE, Xu Y, Isenberg JS, Bachowski S, Kolaja KL, Jiang J, Stevenson DE, Walborg EF, Jr. 1998. The role of oxidative stress in chemical carcinogenesis. Environ Health Perspect 106(Suppl. 1):289-295.
27. Li M, Zhai Q, Bharadwaj U, Wang H, Li F, Fisher WE, Chen C, Yao Q. 2006. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer 106:2284-2294.
28. Lightdale CJ. 1999. Esophageal cancer. American College of Gastroenterology. Am J Gastroenterol 94:20-29.
29. Menell JS, Cesarman GM, Jacovina AT, McLaughlin MA, Lev EA, Hajjar KA. 1999. Annexin II and bleeding in acute promyelocytic leukemia. N Engl J Med 340:994-1004.
30. Montgomerie JZ, Gracy RW, Holshuh HJ, Keyser AJ, Bennett CJ, Schick DG. 1997. The 28K protein in urinary bladder, squamous metaplasia and urine is triosephosphate isomerase. Clin Biochem 30:613-618.
31. Morales CP, Gandia KG, Ramirez RD, Wright WE, Shay JW, Spechler SJ. 2003. Characterisation of telomerase immortalised normal human oesophageal squamous cells. Gut 52:327-333.
32. Nie Y, Yang G, Song Y, Zhao X, So C, Liao J, Wang LD, Yang CS. 2001. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas. Carcinogenesis 22:1615-1623.
33. Nie Y, Liao J, Zhao X, Song Y, Yang GY, Wang LD, Yang CS. 2002. Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma. Carcinogenesis 23:1713-1720.
34. Oka M, Yamamoto K, Takahashi M, Hakozaki M, Abe T, Iizuka N, Hazama S, Hirazawa K, Hayashi H, Tangoku A, Hirose K, Ishihara T, Suzuki T. 1996. Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma. Cancer Res 56:2776-2780.
35. Pinol-Roma S, Swanson MS, Gall JG, Dreyfuss G. 1989. A novel heterogeneous nuclear RNP protein with a unique distribution on nascent transcripts. J Cell Biol 109:2575-2587.
36. Qi Y, Chiu JF, Wang L, Kwong DL, He QY. 2005. Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics 5:2960-2971.
37. Rey O, Baluda MA, Park NH. 1999. Differential gene expression in neoplastic and human papillomavirus-immortalized oral keratinocytes. Oncogene 18:827-831.
38. Shi ST, Yang GY, Wang LD, Xue Z, Feng B, Ding W, Xing EP, Yang CS. 1999. Role of p53 gene mutations in human esophageal carcinogenesis: Results from immunohisto-chemical and mutation analyses of carcinomas and nearby non-cancerous lesions. Carcinogenesis 20:591-597.
39. van de Graaf SF, Hoenderop JG, Gkika D, Lamers D, Prenen J, Rescher U, Gerke V, Staub O, Nilius B, Bindels RJ. 2003. Functional expression of the epithelial Ca(2+) channels (TRPV5 and TRPV6) requires association of the S100A10-annexin 2 complex. EMBO J 22:1478-1487.
40. Vishwanatha JK, Chiang Y, Kumble KD, Hollingsworth MA, Pour PM. 1993. Enhanced expression of annexin II in human pancreatic carcinoma cells and primary pancreatic cancers. Carcinogenesis 14:2575-2579.
41. Wang GQ. 2001.30-year experiences on early detection and treatment of esophageal cancer in high risk areas. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 23:69-72.
42. Wang LD, Zhou Q, Yang CS. 1997. Esophageal and gastric cardia epithelial cell proliferation in northern Chinese subjects living in a high-incidence area. J Cell Biochem Suppl 28-29:159-165.
43. Wang Y, Fang MZ, Liao J, Yang GY, Nie Y, Song Y, So C, Xu X, Wang LD, Yang CS. 2003. Hypermethylation-associated inactivation of retinoic acid receptor beta in human esophageal squamous cell carcinoma. Clin Cancer Res 9:5257-5263.
44. Wong FH, Hu CP, Chiu JH, Huang BS, Chang JP, Lin PJ, Chien KY, Chang C. 1994. Expression of multiple oncogenes in human esophageal carcinomas. Cancer Invest 12:121-131.
45. Wulfkuhle JD, Sgroi DC, Krutzsch H, McLean K, McGar-vey K, Knowlton M, Chen S, Shu H, Sahin A, Kurek R, Wallwiener D, Merino MJ, Petricoin EF III, Zhao Y, Steeg PS. 2002 Proteomics of human breast ductal carcinoma in situ. Cancer Res 62:6740-6749.
46. Xiaoxue Y, Zhongqiang C, Zhaoqing G, Gengting D, Qingjun M, Shenwu W. 2004. Immortalization of human osteoblasts by transferring human telomerase reverse transcriptase gene. Biochem Biophys Res Commun 315: 643-651.
47. Xing EP, Nie Y, Wang LD, Yang GY, Yang CS. 1999a. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China. Carcinogenesis 20:77-84.
48. Xing EP, Yang GY, Wang LD, Shi ST, Yang CS. 1999b. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer. Clin Cancer Res 5:1231-1240.
49. Yang CS. 1980. Research on esophageal cancer in China: A review. Cancer Res 40:2633-2644.
50. Yoshida K, Kyo E, Tsuda T, Tsujino T, Ito M, Niimoto M, Tahara E. 1990. EGF and TGF-alpha, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors. Int J Cancer 45: 131-135.